The challenge of managing mild Parkinson's disease.
Clinicians have a number of options when diagnosing and managing Parkinson's disease. The decision to start pharmacotherapy often depends on the particular needs of the patient and careful weighing of possible benefits, cost, and adverse outcomes. Even mild parkinsonism may require the input of a specialist to obtain the best results.
LeWitt
P A
PA
Department of Neurology, Wayne State University School of Medicine, Detroit, Michigan, USA.
D000978:Antiparkinson Agents / Q000627:therapeutic use*; D018491:Dopamine Agonists / Q000627:therapeutic use*; D006801:Humans; D010300:Parkinson Disease / Q000175:diagnosis / Q000188:drug therapy*; D012720:Severity of Illness Index
D000978:Antiparkinson Agents; D018491:Dopamine Agonists